UnknownNot Applicable

Preferred Reporting Items for Systematic Reviews and Meta-Analyses - Artificial Intelligence Extension

United States150 participantsStarted 2022-06-15

Plain-language summary

The investigators aim to develop the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Artificial Intelligence Extension (PRISMA-AI) guideline as a stand-alone extension of the PRISMA statement, modified to reflect the particular requirements for the reporting of AI and its related topics (namely machine learning, deep learning, neuronal networking) in systematic reviews.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * experts in the use AI technology in medicine * experts in PRISMA * leading authors of STARD-AI, CONSORT-AI, SPIRIT-AI, TRIPOD-AI, PROBAST-AI, CLAIM-AI and DECIDE-AI Exclusion Criteria: * Panelists who were not able to commit to all rounds of the modified Delphi process will be excluded

What they're measuring

Degree of consensus

Timeframe: 3 months

Trial details

NCT IDNCT05382455

SponsorUniversity of Southern California

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More Consensus Development trials